The Prevalence of Doping Among Saudi Athletes: Results from the National Anti-Doping Program

Overview

Journal J Taibah Univ Med Sci

Specialty General Medicine

Date 2020 Feb 29

PMID 32110178

Authors

Sulaiman O Aljaloud

Khalid I Khoshhal

Abdullatif A Al-Ghaiheb

Mohammed S Konbaz

Abdulaziz A Almasaed

Affiliations

Soon will be listed here.

Abstract

Objectives: The abuse of substances banned by anti-doping authorities is a significant problem in sports. Recently, several doping cases have been reported by the media. Additionally, a large number of athletes have been found guilty of using banned substances. Although athletes believe that doping is against the spirit of sports and are aware of its consequences, they continue to use these substances. The consumption of banned substances among Saudi athletes is rising. This study aimed to investigate the abuse of drugs among Saudi athletes.

Methods: A systematic random sampling cross-sectional survey was administered to all 15-45-year-old Saudi male athletes who were registered with Saudi Sports Federations and the General Sports Authority. From 2009 to 2018, 388 doping control officers participated in the National Anti-Doping Program across 460 facilities. The study necessitated 171 city visits for data collection.

Results: A total of 6306 samples were tested during the study period. There were 6165 negative and 141 (2.24%) positive samples for doping. We report a doping prevalence of 2.24% among Saudi athletes. During the study period, Saudi athletes from all types of sports were tested positive for doping. The number of positive samples was significantly higher among competing athletes than non-competing athletes.

Conclusion: Doping is a significant problem in KSA. For safe and fair play by all Saudi athletes, the National Anti-Doping Program should enhance the educational campaigns for all athletes in the country.

References

Krasanakis T, Nikolouzakis T, Sgantzos M, Mariolis-Sapsakos T, Souglakos J, Spandidos D . Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review). Oncol Rep. 2019; 42(6):2228-2244. PMC: 6826302. DOI: 10.3892/or.2019.7351. View

Mountjoy M, Miller S, Vallini M, Foster J, Carr J . International Sports Federation's fight to protect the clean athlete: are we doing enough in the fight against doping?. Br J Sports Med. 2017; 51(17):1241-1242. DOI: 10.1136/bjsports-2017-097870. View

Strano Rossi S, Botre F . Prevalence of illicit drug use among the Italian athlete population with special attention on drugs of abuse: a 10-year review. J Sports Sci. 2011; 29(5):471-6. DOI: 10.1080/02640414.2010.543915. View

Thevis M, Sauer M, Geyer H, Sigmund G, Mareck U, Schanzer W . Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry. J Sports Sci. 2008; 26(10):1059-65. DOI: 10.1080/02640410801910293. View

Laure P . [Doping: epidemiological studies]. Presse Med. 2000; 29(24):1365-72. View

Aljaloud S, Ibrahim S . Use of Dietary Supplements among Professional Athletes in Saudi Arabia. J Nutr Metab. 2013; 2013:245349. PMC: 3677665. DOI: 10.1155/2013/245349. View

Al Ghobain M, Konbaz M, Almassad A, Alsultan A, Al Shubaili M, AlShabanh O . Prevalence, knowledge and attitude of prohibited substances use (doping) among Saudi sport players. Subst Abuse Treat Prev Policy. 2016; 11:14. PMC: 4833935. DOI: 10.1186/s13011-016-0058-1. View

de Hon O, Kuipers H, van Bottenburg M . Prevalence of doping use in elite sports: a review of numbers and methods. Sports Med. 2014; 45(1):57-69. DOI: 10.1007/s40279-014-0247-x. View

Scarpino V, Arrigo A, Benzi G, Garattini S, La Vecchia C, Bernardi L . Evaluation of prevalence of "doping" among Italian athletes. Lancet. 1990; 336(8722):1048-50. DOI: 10.1016/0140-6736(90)92502-9. View

10.

Ama P, Betnga B, Ama Moor V, Kamga J . Football and doping: study of African amateur footballers. Br J Sports Med. 2003; 37(4):307-10. PMC: 1724684. DOI: 10.1136/bjsm.37.4.307. View

11.

Tsatsakis A, Docea A, Calina D, Tsarouhas K, Zamfira L, Mitrut R . A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse. J Clin Med. 2019; 8(9). PMC: 6780697. DOI: 10.3390/jcm8091295. View

12.

Laure P, Lecerf T, Friser A, Binsinger C . Drugs, recreational drug use and attitudes towards doping of high school athletes. Int J Sports Med. 2004; 25(2):133-8. DOI: 10.1055/s-2004-819946. View

13.

Thevis M, Krug O, Geyer H, Walpurgis K, Baume N, Thomas A . Analytical challenges in sports drug testing. Anal Bioanal Chem. 2018; 410(9):2275-2281. DOI: 10.1007/s00216-018-0934-9. View

14.

Ulrich R, Pope Jr H, Cleret L, Petroczi A, Nepusz T, Schaffer J . Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys. Sports Med. 2017; 48(1):211-219. DOI: 10.1007/s40279-017-0765-4. View